|

PD1 Inhibitor Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • The First Affiliated Hospital of Zhengzhou University1

Indications

  • Glutathione1
  • PD1 Antibody1
  • Lung Cancer1
  • Chemotherapy1
  • Non Small Cell Lung Cancer1

Other1 trial

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.